BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22150770)

  • 1. Algorithm for lamotrigine dose adjustment before, during, and after pregnancy.
    Sabers A
    Acta Neurol Scand; 2012 Jul; 126(1):e1-4. PubMed ID: 22150770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure frequency in pregnant women treated with lamotrigine monotherapy.
    Sabers A; Petrenaite V
    Epilepsia; 2009 Sep; 50(9):2163-6. PubMed ID: 19490048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period.
    Fotopoulou C; Kretz R; Bauer S; Schefold JC; Schmitz B; Dudenhausen JW; Henrich W
    Epilepsy Res; 2009 Jul; 85(1):60-4. PubMed ID: 19272754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
    Ohman I; Beck O; Vitols S; Tomson T
    Epilepsia; 2008 Jun; 49(6):1075-80. PubMed ID: 18076642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine in pregnancy and lactation: a case report.
    Tomson T; Ohman I; Vitols S
    Epilepsia; 1997 Sep; 38(9):1039-41. PubMed ID: 9579945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual changes in lamotrigine plasma concentrations during pregnancy.
    Petrenaite V; Sabers A; Hansen-Schwartz J
    Epilepsy Res; 2005 Jul; 65(3):185-8. PubMed ID: 16084694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.
    Ohman I; Vitols S; Tomson T
    Epilepsia; 2000 Jun; 41(6):709-13. PubMed ID: 10840403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium.
    Franco V; Mazzucchelli I; Gatti G; Specchio LM; La Neve A; Papantonio A; Ozkaynakçi AE; Perucca E
    Ther Drug Monit; 2008 Aug; 30(4):544-7. PubMed ID: 18641557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels.
    Fröscher W; Keller F; Vogt H; Krämer G
    Epileptic Disord; 2002 Mar; 4(1):49-56. PubMed ID: 11967180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.
    Pennell PB; Peng L; Newport DJ; Ritchie JC; Koganti A; Holley DK; Newman M; Stowe ZN
    Neurology; 2008 May; 70(22 Pt 2):2130-6. PubMed ID: 18046009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy.
    Ding Y; Tan X; Zhang S; Guo Y
    Brain Behav; 2019 Jul; 9(7):e01315. PubMed ID: 31104352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concentration-effect relationship with lamotrigine (LTG).
    Gidal BE; Welty TE
    Epilepsia; 1997 Feb; 38(2):260. PubMed ID: 9048683
    [No Abstract]   [Full Text] [Related]  

  • 14. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy.
    Gidal BE; Sheth R; Parnell J; Maloney K; Sale M
    Epilepsy Res; 2003 Dec; 57(2-3):85-93. PubMed ID: 15013050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of pregnancy and childbirth on the metabolism of lamotrigine.
    Pennell PB; Newport DJ; Stowe ZN; Helmers SL; Montgomery JQ; Henry TR
    Neurology; 2004 Jan; 62(2):292-5. PubMed ID: 14745072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine in resistant childhood epilepsy.
    Battino D; Buti D; Croci D; Estienne M; Fazio A; Granata T; Pisani F; Rota M; Avanzini G
    Neuropediatrics; 1993 Dec; 24(6):332-6. PubMed ID: 8133979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites.
    Ohman I; Luef G; Tomson T
    Seizure; 2008 Mar; 17(2):199-202. PubMed ID: 18201913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.